Surgalign Holdings, Inc. - SRGAQ STOCK NEWS

Welcome to our dedicated page for Surgalign Holdings news (Ticker: SRGAQ), a resource for investors and traders seeking the latest updates and insights on Surgalign Holdings stock.

Surgalign Holdings, Inc., a medical technology company, specializes in designing, developing, manufacturing, and distributing biologic, metal, and synthetic implants globally. Their product offerings include the coflex interlaminar stabilization device for lumbar spinal stenosis treatment, the simmetry sacroiliac joint fusion system to reduce pain and disability, and the fortilink ibf system with Tetrafuse 3D technology. Surgalign's implants are used in orthopedic, spine, sports medicine, plastic surgery, trauma, and other surgical procedures to repair and promote natural healing. The company markets its products through direct distribution and OEM relationships to healthcare providers, hospitals, and other facilities, as well as through independent distributors. Founded in 1997 and headquartered in Deerfield, IL, Surgalign is dedicated to advancing digital health solutions for superior clinical and economic outcomes worldwide.

07/28/2023 02:00 PM

News

Surgalign Successfully Completes Auction and Names Successful Bidders For Asset Sales

Rhea-AI Summary

Surgalign Holdings has announced the selection of Xtant Medical Holdings and Augmedics as successful bidders for its assets. Xtant will acquire the hardware and biologics assets for a cash purchase price of $5 million, while Augmedics will acquire the digital health assets for $900,000. The bids will help Surgalign move forward with its chapter 11 plan and return value to stakeholders.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

FAQ

What is the market cap of Surgalign Holdings (SRGAQ)?

The market cap of Surgalign Holdings (SRGAQ) is approximately 165.3K.

What does Surgalign Holdings, Inc. specialize in?

Surgalign is a medical technology company that designs, develops, manufactures, and distributes biologic, metal, and synthetic implants globally.

What are some of Surgalign's key products?

Surgalign offers the coflex interlaminar stabilization device, simmetry sacroiliac joint fusion system, and fortilink ibf system with Tetrafuse 3D technology.

How are Surgalign's implants used in medical procedures?

Surgalign's implants are utilized in orthopedic, spine, sports medicine, plastic surgery, trauma, and other surgical procedures to repair and promote natural healing.

Where is Surgalign Holdings, Inc. headquartered?

Surgalign is headquartered in Deerfield, IL, with additional commercial, innovation, and design centers in San Diego, CA, Warsaw and Poznan, Poland, and Wurmlingen, Germany.

When was Surgalign Holdings, Inc. founded?

Surgalign was founded in 1997.

How does Surgalign distribute its products?

Surgalign markets its products through direct distribution, various OEM relationships, healthcare providers, hospitals, other facilities, and a network of independent distributors.

What is Surgalign's commitment regarding digital health?

Surgalign is committed to driving transformation across the surgical landscape by developing technologies that deliver superior clinical and economic outcomes.

What are some recent achievements of Surgalign Holdings, Inc.?

Surgalign recently announced the selection of Xtant Medical Holdings, Inc. and Augmedics, Inc. as successful bidders for its hardware, biologics, and digital health assets during a competitive auction.

Who can be contacted for investor and media relations at Surgalign?

For investor and media relations, contact Glenn Wiener at gwiener@gwcco.com or +1 917 887 8434.

Where can interested parties find more information about Surgalign's chapter 11 proceedings?

Additional information about Surgalign's chapter 11 proceedings can be accessed through the Company's claims agent Kroll Restructuring Administration LLC by visiting https://restructuring.ra.kroll.com/surgalign or by calling +1 (833) 939-6015.